District Business Manager, Cardiovascular - Carolinas at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Lead, coach, and motivate a team of approximately 6-10 TASs to drive adoption of BMS assigned Cardiovascular portfolio and generate demand
Coach TASs on specific learning objectives (selling skills, scientific engagement, and use of digital capabilities)
Ensure continuous improvement in core skills of the team (e.g., scientific agility, customer/commercial mindset, change agility, teamwork/enterprise mindset, patient mindset, digital agility, analytical mindset)
Play a leadership role in business and account planning
Champion utilization of new digital capabilities and tools (e.g., Medical on Call, CE^3)
Inspire and motivate team to reach and exceed business goals while maximizing growth and development potential
Aligned to accounts and cover all Cardiovascular portfolio
Work collaboratively across matrix of Commercial, Medical, Access organizations (e.g., Scientific Engagement Partner (SEP), Field Access Manager (FAM), other field roles)
Field-based role, spending 100% of time in the field with TASs (depending on geographic area)
Report to the Regional Business Director

Responsibilities

Focused in-role coaching and developing of TASs, including conducting selected ride-alongs with TASs for the most important HCPs according to coaching plan
Ownership for TASs learning journey and accountability for continuous improvement in core skills and behavior
Champion adoption of new capabilities (e.g., CE^3 analytics, content personalization)
Understand and role model new capabilities and tools (e.g., sharing knowledge, information, insights, and experiences with new tools with the TAS team)
Effectively coach TASs on new capabilities

Skills

leadership

team management

coaching

sales execution

HCP engagement

pharmaceutical sales

cardiovascular medicine

business management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free